Quarterly report pursuant to Section 13 or 15(d)

Share-based compensation

v2.4.0.6
Share-based compensation
6 Months Ended
Jan. 31, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

Note 3 – Share-based compensation


The Company has an incentive stock option plan (the “1999 Plan”), an incentive stock option and restricted stock award plan (the “2005 Plan”), and a long term incentive share award plan, (the “2011 Incentive Plan”), which are more fully described in Note 9 to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended July 31, 2012. The 2011 Plan, which is the only plan from which awards may now be granted, provides for the award to eligible employees, officers, directors, consultants and other persons of stock options, stock appreciation rights (SARs), restricted stock, restricted stock units, performance awards, and other stock-based awards.


The amounts of share-based compensation expense recognized in the periods presented are as follows:


    Three months ended
January 31,
    Six months ended
January 31,
 
    2013     2012     2013     2012  
Stock options     15             15        
Restricted stock     145       217       286       430  
    $ 160     $ 217     $ 301     $ 430  

The following table sets forth the amount of expense related to share-based payment arrangements included in specific line items in the accompanying statements of operations:


    Three months ended
January 31,
    Six months ended
January 31,
 
    2013     2012     2013     2012  
Cost of clinical laboratory services   $ 2     $ 3     $ 5     $ 5  
Research and development     1       1       1       4  
Selling, general and administrative     157       213       295       421  
    $ 160     $ 217     $ 301     $ 430  

No excess tax benefits were recognized during the three and six month periods ended January 31, 2013 and 2012.


Stock option plans


The following table summarizes stock option activity during the six month period ended January 31, 2013:


    Options     Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual
Term
    Aggregate
Intrinsic
Value (000s)
 
Outstanding at July 31, 2012     736,490     $ 14.50                  
Awarded     336,817     $ 2.88                  
Exercised         $                  
Cancelled     (293,188 )   $ 12.07                  
Outstanding at end of period     780,119     $ 10.39       3.1 years     $ 3  
Options vested at end of period     443,302     $ 16.10       1.4 years     $  

On January 17, 2013, the Company awarded 336,817 options to directors and officers with an exercise price of $2.88 and a five year term, of which 247,672 options vest over two years and 89,145 vest over three years. The weighted average assumptions used to fair value this option award were as follows: expected life of 3.3 years, expected volatility 60.8%, risk free interest rate of 0.45% and no dividend yield. As of January 31, 2013, none of these options were vested.


As of January 31, 2013, the total future compensation cost related to non-vested options, not yet recognized in the statements of operations, was $0.4 million and the weighted average period over which the remaining expense of these awards is expected to be recognized is 2.2 years.


Restricted Stock Awards


A summary of the activity pursuant to the Company’s restricted stock awards for the six months ended January 31, 2013 is as follows:


    Awards     Weighted
Average
Award Price
 
Unvested at July 31, 2012     257,583     $ 3.58  
Awarded     32,000     $ 1.60  
Vested     (97,137 )   $ 2.89  
Forfeited     (3,291 )   $ 5.13  
Unvested at end of period     189,155     $ 3.57  

The fair value of a restricted stock award is determined based on the closing stock price on the award date. As of January 31, 2013, there was approximately $0.4 million of unrecognized compensation cost related to unvested restricted stock-based compensation to be recognized over a weighted average remaining period of approximately one year.


The total number of shares available for grant as equity awards from the 2011 Incentive Plan is approximately 2,320,000 shares as of January 31, 2013.